Family breast cancer history ups ovarian cancer risk

	Tweet

A breast cancer family history, as well as a woman’s age and her own personal history of breast cancer, may help identify women at increased risk of developing ovarian cancer.

A family history of breast cancer has been associated with increased ovarian cancer risk. However, they note that few studies have assessed risk according to a wide variety of traits that suggest an inherited cancer susceptibility disorder.

For their study, Dr. Catherine Schairer and colleagues from the National Cancer Institute, Rockville, Maryland, assessed ovarian cancer according to a detailed breast cancer family history among 49,975 subjects enrolled in a breast cancer study. A total of 362 cases of ovarian cancers were identified during follow-up. 

The team found that having a first- or second-degree relative with breast cancer was associated with a 40 percent increased risk of ovarian cancer (relative risk, 1.4).

The risk was nearly twofold higher among women with two or more affected first-degree relatives (relative risk, 1.8). This was especially true for women diagnosed with ovarian cancer before age 60 or with a personal history of breast cancer.

The highest relative risks were observed among women with a personal history of breast cancer and at least two first-degree relatives with breast cancer, at least one of whom was diagnosed before age 50 or with bilateral breast cancer.

“Knowledge of the familial component of ovarian cancer risk can be used to inform decisions regarding whether to obtain genetic testing, screening, or undertake preventive measures,” Schairer and colleagues conclude.

“In light of ovarian cancer’s tendency to present at a late stage and its attendant high mortality rate, the need to identify women at particularly high risk is clear.”

SOURCE: Cancer September 2006. 

RELATED STORIES:
65% of ovarian cancer cells sideline body’s defences   Research Highlights Important Indicators of Early-stage Ovarian Cancer   Hormone therapy linked to ovarian cancer risk   New platinum-phosphate compounds kill ovarian cancer cells   Finding ovarian cancer fast may not help survival   Ovarian cancer screening saves few lives   Study unmasks how ovarian tumors evade immune system   New Imaging Technique Highlights Cancer During Surgery   Low dose naltrexone (LDN): Harnessing the body’s own chemistry to treat human ovarian cancer   St. John’s wort and polymeric nanoparticles to treat ovarian tumors using light   Low-fat diet possibly linked to lower risk of ovarian cancer   Proteins show promise for ovarian cancer screening   Ginkgo may ward off ovarian cancer   Study Finds Aspirin, Vitamin E Don’t Prevent Cancer   Biological diversity of ovarian cancer lessens value of screening   Late-Stage Ovarian Cancer Therapy Shows Promise in Phase I Trial   Screening misses early ovarian cancer   Genetic factors implicated in survival gap for breast, ovarian or prostate cancer   Combo Promising for Resistant Ovarian Cancer   Short-term OC use cuts ovarian cancer risk   Virus kills ovarian cancer cells   Protein compels ovarian cancer cells to cannibalize themselves

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]